Key statistics
On Friday, Legend Biotech Corp (LEGN:NSQ) closed at 17.10, 5.30% above its 52-week low of 16.24, set on Feb 04, 2026.
52-week range
| Open | 16.88 |
|---|---|
| High | 17.27 |
| Low | 16.88 |
| Bid | 17.11 |
| Offer | 17.28 |
| Previous close | 16.70 |
| Average volume | 2.58m |
|---|---|
| Shares outstanding | 184.69m |
| Free float | 182.84m |
| P/E (TTM) | -- |
| Market cap | 3.08bn USD |
| EPS (TTM) | -1.30 USD |
Data delayed at least 15 minutes, as of Feb 06 2026 21:00 GMT.
More ▼
- Legend Biotech to Present CARVYKTI® Data at 2026 Tandem Meetings Reinforcing Growing Evidence Supporting Earlier Use
- Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference
- Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025
- Legend Biotech Awarded 2025 FIBA Foreign Investor of the Year by Flanders Investment & Trade
- Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia
- Legend Biotech Reports Third Quarter 2025 Results and Recent Highlights
- Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology (ASH) Annual Meeting
- Legend Biotech to Host Investor Conference Call on Third Quarter 2025 Results
- Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference
More ▼
